November 18, 2016 - By Vivian Park · 0 Comments
The stock of Varian Medical Systems Incorporated (NYSE:VAR) registered a decrease of 2.04% in short interest. VAR’s total short interest was 7.57M shares in November as published by FINRA. Its down 2.04% from 7.73 million shares, reported previously. With 576,300 shares average volume, it will take short sellers 13 days to cover their VAR’s short positions. The short interest to Varian Medical Systems Incorporated’s float is 8.13%. About 446,421 shares traded hands. Varian Medical Systems, Inc. (NYSE:VAR) has risen 5.31% since April 18, 2016 and is uptrending. It has outperformed by 0.88% the S&P500.
Varian Medical Systems Inc. is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy. The company has a market cap of $8.33 billion. The Firm is a supplier of X-ray imaging components for medical, scientific, and industrial applications and supplies X-ray imaging products for cargo screening and industrial inspection. It has a 21.05 P/E ratio. The Firm offers tools for fighting cancer, taking X-ray images and protecting ports and borders.
Insitutional Activity: The institutional sentiment decreased to 0.89 in 2016 Q2. Its down 0.04, from 0.93 in 2016Q1. The ratio dived, as 37 funds sold all Varian Medical Systems, Inc. shares owned while 180 reduced positions. 39 funds bought stakes while 163 increased positions. They now own 92.56 million shares or 3.46% less from 95.88 million shares in 2016Q1.
Shinko Asset Management Limited holds 0% or 2,353 shares in its portfolio. Cannell Peter B & Co last reported 0.52% of its portfolio in the stock. California Employees Retirement Systems holds 0.04% of its portfolio in Varian Medical Systems, Inc. (NYSE:VAR) for 284,700 shares. Deere And holds 0.02% or 4,284 shares in its portfolio. Employees Retirement Association Of Colorado reported 20,010 shares or 0.01% of all its holdings. Gateway Invest Advisers Ltd Liability has 0% invested in the company for 6,761 shares. Ladenburg Thalmann Svcs accumulated 0% or 951 shares. Hightower Ltd holds 55,207 shares or 0.06% of its portfolio. The Maine-based Schroder Inv Mgmt Gp has invested 0.06% in Varian Medical Systems, Inc. (NYSE:VAR). Her Majesty The Queen In Right Of The Province Of Alberta As Represented By Alberta Invest Management Corp, a Alberta – Canada-based fund reported 211,500 shares. Cohen Klingenstein Ltd Liability Corp holds 0.29% or 19,200 shares in its portfolio. Blackrock Japan accumulated 0.04% or 119,667 shares. Moreover, Nomura Asset Mgmt has 0.11% invested in Varian Medical Systems, Inc. (NYSE:VAR) for 72,730 shares. Moreover, Wellington Mgmt Ltd Liability Partnership has 0.03% invested in Varian Medical Systems, Inc. (NYSE:VAR) for 1.32M shares. Moreover, Bartlett And Ltd Co has 0.03% invested in Varian Medical Systems, Inc. (NYSE:VAR) for 7,560 shares.
Insider Transactions: Since June 3, 2016, the stock had 0 insider purchases, and 16 sales for $13.01 million net activity. Shares for $191,646 were sold by FINNEY ELISHA W on Thursday, September 1. The insider WILSON DOW R sold 10,000 shares worth $951,425. Another trade for 21,266 shares valued at $2.21M was sold by KUO JOHN W. $128,969 worth of Varian Medical Systems, Inc. (NYSE:VAR) was sold by LARET MARK R. GUERTIN TIMOTHY E sold $379,519 worth of Varian Medical Systems, Inc. (NYSE:VAR) on Monday, August 1. Another trade for 9,483 shares valued at $899,756 was made by VERHOEF CLARENCE R on Monday, August 1. NAUMANN-ETIENNE RUEDIGER sold $84,831 worth of stock or 1,000 shares.
Out of 8 analysts covering Varian Medical Systems Inc. (NYSE:VAR), 3 rate it a “Buy”, 1 “Sell”, while 4 “Hold”. This means 38% are positive. Varian Medical Systems Inc. has been the topic of 11 analyst reports since August 27, 2015 according to StockzIntelligence Inc. The firm has “Sector Perform” rating by RBC Capital Markets given on Tuesday, December 22. The firm has “Sell” rating by Goldman Sachs given on Monday, September 28. Robert W. Baird downgraded it to “Neutral” rating and $82 target price in Tuesday, October 20 report. Barrington Research reinitiated the stock with “Outperform” rating in Tuesday, January 12 report. The stock has “Neutral” rating given by Citigroup on Thursday, November 12. The stock has “Neutral” rating given by Robert W. Baird on Wednesday, September 28. The rating was maintained by Brean Capital on Thursday, April 28 with “Buy”.
Varian Medical Systems, Inc., incorporated on January 22, 1976, makes medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy. The Firm supplies X-ray imaging components for medical, scientific, cargo screening and industrial applications. The Company’s divisions include Oncology Systems, Imaging Components and Other. The Firm offers a range of post-warranty equipment service contracts and software support contracts. The Company’s domestic service centers are in Milpitas, California; Las Vegas, Nevada, and Atlanta, Georgia. The Company’s international service centers are in France, the United Kingdom, Switzerland, Denmark, Belgium, Germany, the Netherlands, Spain and Italy, among others.
More notable recent Varian Medical Systems, Inc. (NYSE:VAR) news were published by: Forbes.com which released: “Short Interest In Varian Medical Systems Moves 15.4% Lower” on November 11, 2016, also Prnewswire.com with their article: “Varian Medical Systems Announces Upcoming Investor Events” published on October 31, 2016, Reuters.com published: “Varian Medical Systems draws well-timed option bets” on October 20, 2016. More interesting news about Varian Medical Systems, Inc. (NYSE:VAR) were released by: Prnewswire.com and their article: “Varian Medical Systems Reports Results for Fourth Quarter of Fiscal Year 2016” published on October 26, 2016 as well as Forbes.com‘s news article titled: “Varian Medical Systems Reaches Analyst Target Price” with publication date: July 28, 2016.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.
By Vivian Park